檢索結果 - STEAL Study Group

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. 由 Hila Haskelberg, Jennifer F Hoy, Janaki Amin, Peter R Ebeling, Sean Emery, Andrew Carr, STEAL Study Group

    發表在 PLoS ONE (2012-01-01)
    獲取全文
    Article


  2. 2

    HLA alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine. 由 Hila Haskelberg, Damien V Cordery, Janaki Amin, Anthony D Kelleher, David A Cooper, Sean Emery, STEAL Study Group

    發表在 PLoS ONE (2014-01-01)
    獲取全文
    Article


  3. 3

    Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or abacavir-lamivudine. 由 Allison Martin, Janaki Amin, Sean Emery, David Baker, Andrew Carr, David A Cooper, Mark Bloch, STEAL Study Group

    發表在 PLoS ONE (2011-01-01)
    獲取全文
    Article


檢索工具: